Burning Rock Biotech Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2020 to Q4 2023

Taxonomy & unit: us-gaap: CNY and USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Burning Rock Biotech Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2020 to Q4 2023.
Burning Rock Biotech Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending December 31, 2023 was $17.9M, a 12.1% increase year-over-year.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$17.9M	+$1.93M	+12.1%	Dec 31, 2023	20-F	2024-04-29
Q4 2022	$15.9M	+$1.47M	+10.2%	Dec 31, 2022	20-F	2023-04-20
Q2 2022	$15.1M			Jun 30, 2022	6-K	2022-11-07
Q4 2021	$14.5M	+$948K	+7.01%	Dec 31, 2021	20-F	2022-04-29
Q4 2020	$13.5M			Dec 31, 2020	20-F	2021-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.